Target intelligence / Profile preview

Skin absorption pathway

Molecular classification
Other
01

Overview

The skin absorption pathway refers to the mechanisms by which substances applied to the skin surface penetrate the stratum corneum and are transported into the viable epidermis, dermis, and potentially systemic circulation. Absorption depends on both drug properties (size, lipophilicity, solubility), anatomical skin site, integrity/hydration of the stratum corneum, and the presence of appendages such as hair follicles and sebaceous/sweat glands. The main mechanisms are: - Passive diffusion: Most common, driven by concentration gradient, especially for small, lipophilic molecules. - Active transport: Rare, requires carrier proteins and energy expenditure, more relevant for certain polar and large molecules. - Appendageal/Transappendageal route: Utilizes hair follicles and glands, important for large and polar compounds, also serves as reservoirs. - Transcellular and Intercellular penetration: Drug molecules can move through cells (transcellular, especially hydrophobic compounds) or between cells (intercellular, mostly lipophilic molecules). The rate and extent of skin absorption are limited primarily by the properties of the outer stratum corneum and can be enhanced by increasing skin hydration or disrupting the barrier. The pathway is fundamental to transdermal drug delivery and also constitutes a route of unintentional exposure to toxic substances. Unlike specific targets such as receptors or enzymes, the skin absorption pathway is a physical route, not a molecular or protein entity.

Other names
Percutaneous absorption pathwayDermal absorption routeTransdermal absorption pathway
02

Mechanism of action

Not applicable (drugs leverage this pathway for systemic or local delivery, mechanisms include passive diffusion, active transport, and appendageal penetration)

03

Biological functions

Barrier to xenobiotic entryDrug absorption/deliveryEnvironmental exposureRegulation of homeostatic hydration and chemical exchange
04

Disease associations

Other (not directly implicated in disease, but relevant to exposure and drug delivery)
05

Safety considerations

Variability in absorption dependent on skin siteRisks of enhanced systemic toxicity if barrier compromisedUnintended absorption of environmental toxinsSpecies and age-related differences in permeabilitySkin irritation, allergic reactions, sensitizationDifficulty controlling dose precision compared to oral or injectable routes
06

Interacting drugs

fentanyl patches

2 more in the full profile.

Beyond the preview

Go deeper on Skin absorption pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin absorption pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call